ABT

Abbott Laboratories
D

ABT

Arincen83/100B

Abbott Laboratories shares outstanding 1985–2026

Abbott Laboratories had 1,730,383,296 shares outstanding on 4 November 2026. Abbott Laboratories had 1.74B diluted shares on average over the last twelve months, down 0.3% on the twelve months before. In fiscal year 2025 the average was 1.75B.

Last updated 3 Nov 2026 · Next report 28 Jan 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 20261.74B-0.26%1.74B
FY202531 Dec 20251.75B-0.06%1.75B
FY202431 Dec 20241.75B-0.06%1.73B
FY202331 Dec 20231.75B-0.85%1.73B
FY202231 Dec 20221.76B-1.40%1.75B
FY202131 Dec 20211.79B+0.17%1.78B
FY202031 Dec 20201.79B+0.28%1.77B
FY201931 Dec 20191.78B+0.62%1.77B
FY201831 Dec 20181.77B+1.20%1.76B
FY201731 Dec 20171.75B+17.94%1.74B
FY201631 Dec 20161.48B-1.53%1.47B
FY201531 Dec 20151.51B-1.38%1.47B
FY201431 Dec 20141.53B-2.99%1.51B
FY201331 Dec 20131.57B-1.13%1.55B
FY201231 Dec 20121.59B+1.57%1.58B
FY201131 Dec 20111.57B+0.73%1.56B
FY201031 Dec 20101.56B+0.06%1.55B
FY200931 Dec 20091.56B-0.36%1.55B
FY200831 Dec 20081.56B+0.04%1.55B
FY200731 Dec 20071.56B+1.52%1.54B
FY200631 Dec 20061.54B-1.75%1.53B
FY200531 Dec 20051.56B-0.41%1.55B
FY200431 Dec 20041.57B-0.08%1.56B
FY200331 Dec 20031.57B-0.09%1.56B
FY200231 Dec 20021.57B+0.46%1.56B
FY200131 Dec 20011.57B+0.03%1.55B
FY200031 Dec 20001.57B+0.51%1.55B
FY199931 Dec 19991.56B-0.21%1.54B
FY199831 Dec 19981.56B-0.90%1.54B
FY199731 Dec 19971.58B-0.41%1.55B
FY199631 Dec 19961.58B-0.82%1.56B
FY199531 Dec 19951.59B-1.84%1.59B
FY199431 Dec 19941.62B-2.02%1.62B
FY199331 Dec 19931.66B-0.98%1.66B
FY199231 Dec 19921.67B-1.57%1.67B
FY199131 Dec 19911.70B-1.36%1.70B
FY199031 Dec 19901.72B-1.71%1.72B
FY198931 Dec 19891.75B-2.00%1.75B
FY198831 Dec 19881.79B-0.94%1.79B
FY198731 Dec 19871.81B-3.02%1.81B
FY198631 Dec 19861.86B+0.14%1.86B
FY198531 Dec 19851.86B—1.86B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Abbott Laboratories's shares

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.